London launches new cancer drug development hub
February 3, 2016Research and Development
Research charities, hospitals, and London boroughs have combined to launch a new global hub for cancer research and treatment in …
GSK and Adaptimmune expand R&D collaboration
February 3, 2016Research and Development Adaptimmune, GSK, T-cell therapy, immunotherapy, liposarcoma, rare cancer, sarcoma
Adaptimmune Therapeutics and GlaxoSmithKline have expanded the terms of their strategic collaboration agreement, to run clinical trials of Adaptimmune’s potential …
Daiichi Sankyo to expand access to clinical trial data
February 3, 2016Research and Development Daiichi Sankyo, R&D, clinical trials, open access, open data, transparency
Daiichi Sankyo has announced today that it will share clinical trial data to qualified researchers through an online web request …
Sanofi plans R&D jobs cuts in France
February 3, 2016Manufacturing and Production, Research and Development Sanofi, Teva, cuts, job losses, olivier brandicourt, redundancies
Sanofi chief executive Olivier Brandicourt is reported to be planning hundreds of job cuts across the firm’s base in France, …
Pfizer revenues down, but above expectations
February 3, 2016Research and Development, Sales and Marketing Ian Read, Pfizer, financial results, income, profits, revenue, sales
Pfizer’s revenues took a hit from generic competition on former blockbusters, but the world’s new largest drugmaker still managed to …
Crescendo Biologics appoints Dr Barbara Fleck as head of intellectual property
February 2, 2016Research and Development Crescendo Biologics
Drug discovery and developer Crescendo Biologics has appointed Dr Barbara Fleck as head of intellectual property. Barbara Fleck, a European and …
PCI and Partners host San Diego and San Francisco Serialization events
February 2, 2016Manufacturing and Production
Professionals working in life science packaging and logistics can learn more about the fast-changing topic of Serialization at two free …
Porton Biopharma expands cancer drug manufacturing capacity
February 2, 2016Manufacturing and Production, Research and Development Erwinase
UK Life Sciences Minister George Freeman yesterday opened a new multi-million pound pharmaceutical manufacturing facility at Wiltshire-based Porton Biopharma Limited …
Sun Pharma takes on Novartis in the US with generic Glivec
February 2, 2016Manufacturing and Production, Research and Development, Sales and Marketing Gleevec, Novartis, Sun Pharma
Mumbai-based drug manufacturer Sun Pharma has launched a generic version of Glivec, for the same indications for which the former …
Sanofi Pasteur launches Zika vaccine R&D
February 2, 2016Manufacturing and Production, Research and Development Sanofi Pasteur, Vaccine, Zika virus
Sanofi Pasteur, the vaccines division of French pharma giant Sanofi, says it has launched a vaccine research and development project …
Europe approves BMS hep C drug for HIV and liver transplant patients
February 1, 2016Research and Development, Sales and Marketing Bristol-Myers Squibb, daclatasvir, daklinza
The European Commission has approved the expanded use of Bristol Myers-Squibb’s hepatitis C drug Daklinza (daclatasvir), to include liver transplant …
AbbVie posts strong Q4 results
February 1, 2016Sales and Marketing AbbVie, Humira, Viekira Pak
AbbVie managed to meet or beat analysts’ expectations in its Q4 financial results report, with extremely strong Humira sales contributing …
PwC appoints Issy Corbett as healthcare M&A partner
February 1, 2016Sales and Marketing pwC
PwC has appointed Issy Corbett as a partner to lead its healthcare M&A team.Corbett joins PwC from Rothschild, where he …
Contigency plans in place while Smith & Nephew boss has cancer treatment
February 1, 2016Manufacturing and Production Olivier Bohuon, Smith & Nephew, medical devices
Medical technology firm Smith & Nephew has announced that chief executive Olivier Bohuon has been diagnosed with a ‘highly treatable …
Merck launches health tech start-up program in Africa
February 1, 2016Manufacturing and Production, Medical Communications, Research and Development
Merck has begun its equity-free accelerator program for digital health start-ups in Nairobi, Kenya- a three-month venture offering $15,000 equity-free …
Ministers reject bid to revive Off Patent Drugs Bill
February 1, 2016Research and Development, Sales and Marketing Access to Medical Treatments (Innovation) Bill, Off Patent Drugs Bill, Off-Patent Drugs Bill, george freeman, parliament, repurposing drugs
Ministers have rejected amendments to a proposed Parliamentary Bill that sought to reintroduce elements of the Off Patent Drugs Bill, …
Actelion’s Uptravi and rare bleeding disorder drug get positive EMA decisions
February 1, 2016Sales and Marketing CHMP, EMA, Uptravi, pulmonary arterial hypertension, selexipag
The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the EMA, has issued positive opinions on …
EMA fast-tracks BMS multiple myeloma drug
February 1, 2016Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, EMA, Empliciti, myeloma
The EMA has recommended granting a marketing authorisation for Bristol Myers-Squibb and AbbVie’s immunotherapy Empliciti for the treatment of multiple myeloma. The …
Gilead Sciences names John Milligan new CEO
January 29, 2016Medical Communications, Sales and Marketing Gilead Sciences, John Martin, John Milligan
Gilead Sciences has announced that chairman and chief executive John Martin is to step down after 20 years at the …
Allergan’s depression drug awarded FDA Breakthrough Therapy status
January 29, 2016Research and Development, Sales and Marketing Allergan, depression, rapastinel
While still adjusting to life as part of Pfizer, Allergan has received some good news in the form of the …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
